A man with a ‘huge appetite’ could cure cancer with a simple tweak
Health officials in Maryland have identified a rare mutation that could make a patient more susceptible to cancer, and have developed a treatment that may work on any tumour.
Maryland Public Health and the Johns Hopkins University’s School of Medicine announced the findings in the journal Cell on Wednesday.
The mutation, which is associated with the development of a cancerous growth in the body, was identified in a small number of patients with lymphoma and breast cancer, but could be spread to other types of cancers, the study authors said.
They believe the mutation, known as a KAL6A1, affects more than 2,000 people, including those who have been diagnosed with a cancer or leukemia.
KAL6 is also known as an “endogenous KAL7”, which means it can be passed from parent to child, the researchers said.
They say their results show that KAL4a, which the mutation affects, can also cause cancer, with results similar to that of the KAL5a mutation.
There are currently no therapies for KAL2a, but there is hope that the mutation could lead to the development and use of new therapeutic drugs.
“These findings will likely accelerate the development or use of the next generation of anticancer drugs,” said lead author Dr. Robert Fink, a researcher at Johns Hopkins.
“These drugs could be effective in a fraction of the cases that they cause in humans, and in some cases in fewer than a dozen cases.
This may provide a novel, targeted approach to the management of some cancers.”
However, these therapies will not have the same efficacy as the traditional approach that has been used for decades.
“The researchers say the mutation is also a risk factor for breast cancer.”
There is a very high incidence of breast cancer in women who have the KALS mutation,” said Dr. Michael A. Bohn, director of the Johns Johns Hopkins Center for Human Genetics, who was not involved in the study.”
We think that the breast cancer risk is increased because this mutation predisposes the patient to breast cancer.
“Dr. Bohm is one of several researchers to link KAL-4a to breast cancers, and the study shows that it may also be passed on to a child or teenager.
According to the American Cancer Society, there are about 400,000 new cases of breast and ovarian cancer each year.